phase 1_completion
saveRevolution Medicines Inc — daraxonrasib (Phase I Trial Completion)
community read0 votes
Therapy area: Oncology. Indication: Colorectal Cancer, Non-Small Cell Lung Cancer, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Solid Tumor